MoreBack to News Headlines

J&J scientists refute ‘class effect’ to blame for clots in those who got its vaccine
The Hindu
They say the two vaccines are ‘substantially different’ and have different effects
Scientists at Johnson & Johnson on April 16 refuted an assertion in a major medical journal that the design of their COVID-19 vaccine, which is similar AstraZeneca’s, may explain why both have been linked to very rare brain blood clots in some vaccine recipients. The U.S. earlier this week paused distribution of the J&J vaccine to investigate six cases of a rare brain blood clot known as cerebral venous sinus thrombosis (CVST), accompanied by a low blood platelet count, in U.S. women under age 50, out of about 7 million people who got the shot. The blood clots in patients who received the J&J vaccine bear close resemblance to 169 cases in Europe reported with the AstraZeneca vaccine, out of 34 million doses administered there.More Related News

KTM has reinforced its middleweight ADV portfolio in India with the introduction of two distinct offerings — the updated KTM 390 Adventure X and the globally-spec KTM 390 Adventure Enduro R. While the former caters to long-distance touring enthusiasts now seeking more value and tech, the latter is purpose-built for riders who demand uncompromised off-road performance, rooted in Dakar DNA.